Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease
- PMID: 3846883
Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease
Abstract
As a prelude to clinical trials with a bovine surfactant (surfactant TA), in human infants with hyaline membrane disease, pulmonary and hemodynamic changes following its instillation in premature baboons were investigated. Baboons, delivered by cesarean section at 141 +/- 3.5 days (mean +/- SD, 77% gestation), were provided with intensive care. At 2 hours of age in one group (n = 10), 100 mg/kg of surfactant TA (reconstituted bovine surfactant, Tokyo Tanabe Co., Tokyo) was instilled into the lungs. Sequential measurements and monitoring of pulmonary and hemodynamic variables were carried out in these ten baboons and in a control group of five baboons for 16 hours, at which time the experiments were electively terminated. At birth, the pulmonary compliance, findings of chest radiographs, ratio of arterial PO2 to alveolar PO2, and respirator variables needed to maintain normal blood gas and acid base status were identical in both groups and indicative of severe hyaline membrane disease. Following surfactant instillation, the treated group demonstrated a rapid increase in PO2 with significantly improved ratio of arterial PO2 to alveolar PO2 (from a mean +/- SD pretreatment value of 0.21 +/- 0.11 to 0.45 +/- 0.11 by 16 hours). Pulmonary compliance improved similarly (from pretreatment value of 0.18 +/- 0.06 mL/cm H2O/kg to 0.27 +/- 0.09 mL/cm H2O/kg). Significant reduction in respirator support variables could be achieved in all treated animals; however, in the control animals, the pulmonary status worsened as evidenced by increasing mean airway pressure and respirator variables to keep normal blood gas and acid base status, thus worsening compliance. At autopsy, pulmonary pressure-volume curves were significantly different with large hysteresis obtained in the surfactant-treated group. Although no deleterious effect on hemodynamics was noted in surfactant TA-treated animals, a large patent ductus arteriosus was demonstrated by aortography. Increased lung blood flow, probably due to a large patent ductus arteriosus flow, was demonstrated by radiolabeled microsphere technique. The physiologic significance and clinical relevance of these findings in premature baboons treated with surfactant TA are discussed.
Similar articles
-
Early and late surfactant treatments in baboon model of hyaline membrane disease.Pediatrics. 1988 Feb;81(2):277-83. Pediatrics. 1988. PMID: 3340477
-
Treatment of patent ductus arteriosus after exogenous surfactant in baboons with hyaline membrane disease.Pediatr Res. 1989 Dec;26(6):565-9. doi: 10.1203/00006450-198912000-00010. Pediatr Res. 1989. PMID: 2602035
-
Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease.Pediatrics. 1987 Jan;79(1):31-7. Pediatrics. 1987. PMID: 3540835 Clinical Trial.
-
Pulmonary surfactant replacement in respiratory distress syndrome.Clin Perinatol. 1987 Dec;14(4):991-1015. Clin Perinatol. 1987. PMID: 3322633 Review.
-
[Administration of surfactant in hyaline membrane disease].An Esp Pediatr. 1987 Sep;27(3):147-51. An Esp Pediatr. 1987. PMID: 3322119 Review. Spanish. No abstract available.
Cited by
-
Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.Arch Dis Child Fetal Neonatal Ed. 1994 Jan;70(1):F19-24. doi: 10.1136/fn.70.1.f19. Arch Dis Child Fetal Neonatal Ed. 1994. PMID: 8117122 Free PMC article. Clinical Trial.
-
Acute effects of instillation of surfactant in severe respiratory distress syndrome.Arch Dis Child. 1989 Jan;64(1 Spec No):13-6. doi: 10.1136/adc.64.1_spec_no.13. Arch Dis Child. 1989. PMID: 2647040 Free PMC article. Clinical Trial.
-
In vivo distribution of human milk leucocytes after ingestion by newborn baboons.Arch Dis Child. 1989 Jul;64(7 Spec No):930-3. doi: 10.1136/adc.64.7_spec_no.930. Arch Dis Child. 1989. PMID: 2774634 Free PMC article.
-
Early changes in lung function and response to surfactant replacement therapy.Eur J Pediatr. 1994 Jul;153(7):495-500. doi: 10.1007/BF01957004. Eur J Pediatr. 1994. PMID: 7957366 Clinical Trial.
-
Hemodynamic consequences of respiratory interventions in preterm infants.J Perinatol. 2022 Sep;42(9):1153-1160. doi: 10.1038/s41372-022-01422-5. Epub 2022 Jun 11. J Perinatol. 2022. PMID: 35690691 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials